HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.

Abstract
Alternative splicing (AS) allows generation of cell type-specific mRNA transcripts and contributes to hallmarks of cancer. Genome-wide analysis for AS in human hepatocellular carcinoma (HCC), however, is limited. We sought to obtain a comprehensive AS landscape in HCC and define tumor-associated variants. Single-molecule real-time long-read RNA sequencing was performed on patient-derived HCC cells, and presence of splice junctions was defined by SpliceMap-LSC-IDP algorithm. We obtained an all-inclusive map of annotated AS variants and further discovered 362 alternative spliced variants that are not previously reported in any database (neither RefSeq nor GENCODE). They were mostly derived from intron retention and early termination codon with an in-frame open reading frame in 81.5%. We corroborated many of these predicted unannotated and annotated variants to be tumor specific in an independent cohort of primary HCC tumors and matching nontumoral liver. Using the combined Sanger sequencing and TaqMan junction assays, unique and common expressions of spliced variants including enzyme regulators (ARHGEF2, SERPINH1), chromatin modifiers (DEK, CDK9, RBBP7), RNA-binding proteins (SRSF3, RBM27, MATR3, YBX1), and receptors (ADRM1, CD44v8-10, vitamin D receptor, ROR1) were determined in HCC tumors. We further focused functional investigations on ARHGEF2 variants (v1 and v3) that arise from the common amplified site chr.1q22 of HCC. Their biological significance underscores two major cancer hallmarks, namely cancer stemness and epithelial-to-mesenchymal transition-mediated cell invasion and migration, although v3 is consistently more potent than v1. Conclusion: Alternative isoforms and tumor-specific isoforms that arise from aberrant splicing are common during the liver tumorigenesis. Our results highlight insights gained from the analysis of AS in HCC.
AuthorsHui Chen, Feng Gao, Mian He, Xiao Fan Ding, Aikha M Wong, Siu Ching Sze, Allen C Yu, Tingting Sun, Anthony W-H Chan, Xin Wang, Nathalie Wong
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 70 Issue 3 Pg. 1011-1025 (09 2019) ISSN: 1527-3350 [Electronic] United States
PMID30637779 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases.
Chemical References
  • Chromosomal Proteins, Non-Histone
  • DEK protein, human
  • Oncogene Proteins
  • Poly-ADP-Ribose Binding Proteins
  • Protein Isoforms
  • ROR1 protein, human
  • Receptor Tyrosine Kinase-like Orphan Receptors
Topics
  • Alternative Splicing
  • Carcinogenesis (genetics)
  • Carcinoma, Hepatocellular (genetics, pathology)
  • Chromosomal Proteins, Non-Histone (genetics)
  • Gene Expression Regulation, Neoplastic (genetics)
  • Genome-Wide Association Study
  • Humans
  • Liver Neoplasms (genetics, pathology)
  • Oncogene Proteins (genetics)
  • Poly-ADP-Ribose Binding Proteins (genetics)
  • Protein Isoforms (genetics)
  • RNA Splicing
  • Receptor Tyrosine Kinase-like Orphan Receptors (genetics)
  • Sensitivity and Specificity
  • Sequence Analysis, RNA (methods)
  • Tumor Cells, Cultured
  • Exome Sequencing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: